Suzhou Abogen Biosciences Co., Ltd.
Clinical trials sponsored by Suzhou Abogen Biosciences Co., Ltd., explained in plain language.
-
MRNA shot takes aim at the nerve pain of shingles
Vaccine Recruiting nowResearchers are testing an experimental mRNA vaccine called ABO1108 to see whether it can prevent herpes zoster, the painful rash also known as shingles. The trial enrolls adults aged 40 and older, including people whose long-term conditions are stable. Participants receive two i…
Phase 3 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: Vaccine
Last updated Sep 16, 2026 00:00 UTC
-
New mRNA vaccine takes on tough cancers
Disease control Recruiting nowThis early-stage trial tests a new mRNA vaccine called ABO2102, designed to target cancers with specific KRAS mutations. About 101 adults with advanced solid tumors will receive the vaccine alone or with another drug (Sintilimab). The study focuses on safety and how the body resp…
Phase 1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC